Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Treatment with FOXO4-DRI reduces hydroxyproline content in lung tissue, a direct measure of collagen deposition, and improves lung histology assessed by hematoxylin-eosin and Masson trichrome staining
Supplied in sealed laboratory containers, this product is intended for analytical, investigational, and method development activities where consistency, handling control, and traceability are required
Additionally, preclinical tendon and ligament injury models show improved fibroblast recruitment and organized collagen deposition
Refrigerated storage preserves peptide stability across short-term usage periods
Martineau AR, Jolliffe DA, Hooper RL, et al
US$ 26.57
US$ 23.70
US$ 23.01
US$ 27.56
US$ 28.45
US$ 23.55
US$ 25.52
US$ 21.81
US$ 28.66
US$ 27.37
US$ 25.37
